Researchers validate preclinical effectiveness of TB drug target
In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten ...
Nov 29, 2011
0
0